Overexpression of TGF-β by infiltrated granulocytes correlates with the expression of collagen mRNA in pancreatic cancer
暂无分享,去创建一个
T. Oda | Y. Aoyagi | Atsushi Ochiai | N. Ohkohchi | A. Ochiai | T. Hasebe | T. Kinoshitá | T Hasebe | T Kinoshita | A Ochiai | N Ohkohchi | Y Aoyagi | T Oda | C Nakahashi | C. Nakahashi | Chigusa Nakahashi
[1] H. Friess,et al. Overexpression of acidic and basic fibroblast growth factors in human pancreatic cancer correlates with advanced tumor stage. , 1993, Cancer research.
[2] P. Colville-Nash,et al. Temporal and spatial immunolocalization of cytokines in murine chronic granulomatous tissue. Implications for their role in tissue development and repair processes. , 1993, Laboratory investigation; a journal of technical methods and pathology.
[3] M. Sporn,et al. Transforming growth factor beta. , 1988, Advances in cancer research.
[4] K. Takehara,et al. Induction of subcutaneous tissue fibrosis in newborn mice by transforming growth factor beta-simultaneous application with basic fibroblast growth factor causes persistent fibrosis. , 1997, Biochemical and biophysical research communications.
[5] M. Imamura,et al. Quantitative Analysis of Collagen and Collagen Subtypes I, III, and V in Human Pancreatic Cancer, Tumor‐Associated Chronic Pancreatitis, and Alcoholic Chronic Pancreatitis , 1995, Pancreas.
[6] J. Rosenbloom,et al. Transforming growth factor beta (TGF beta) causes a persistent increase in steady-state amounts of type I and type III collagen and fibronectin mRNAs in normal human dermal fibroblasts. , 1987, The Biochemical journal.
[7] H. Friess,et al. Induction of platelet‐derived growth factor A and B chains and over‐expression of their receptors in human pancreatic cancer , 1995, International journal of cancer.
[8] H. Friess,et al. Adjuvant therapy in pancreatic cancer: historical and current perspectives. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.
[9] J. Malin,et al. Expression of tumor necrosis factor-alpha and transforming growth factor-beta 1 in cerebrospinal fluid cells in meningitis. , 1996, Journal of the neurological sciences.
[10] D. Wong,et al. Eosinophils from patients with blood eosinophilia express transforming growth factor beta 1. , 1991, Blood.
[11] N. Khalil. TGF-β: from latent to active , 1999 .
[12] M. Sporn,et al. Expression and secretion of type beta transforming growth factor by activated human macrophages. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[13] K. Sekizawa,et al. Increases in collagen type I synthesis in asthma: the role of eosinophils and transforming growth factor‐bβ , 2002, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[14] W. Schürch,et al. Differentiation repertoire of fibroblastic cells: expression of cytoskeletal proteins as marker of phenotypic modulations. , 1990, Laboratory investigation; a journal of technical methods and pathology.
[15] M. Krupsky,et al. Regulation of type I collagen production by insulin and transforming growth factor-beta in human lung fibroblasts. , 1996, Connective tissue research.
[16] E. Castaños-Vélez,et al. Immunohistochemical expression of extracellular matrix proteins and adhesion molecules in pancreatic carcinoma. , 2001, Hepato-gastroenterology.
[17] Gary R. Grotendorst,et al. Stimulation of fibroblast cell growth, matrix production, and granulation tissue formation by connective tissue growth factor. , 1996, The Journal of investigative dermatology.
[18] J. Malin,et al. Expression of tumor necrosis factor-α and transforming growth factor-β1 in cerebrospinal fluid cells in meningitis , 1996, Journal of the Neurological Sciences.
[19] E. Tahara. Growth factors and oncogenes in human gastrointestinal carcinomas , 2005, Journal of Cancer Research and Clinical Oncology.
[20] A. Fine,et al. The effect of transforming growth factor-beta on cell proliferation and collagen formation by lung fibroblasts. , 1987, The Journal of biological chemistry.
[21] H. Kern,et al. Histological and fine structural features of pancreatic ductal adenocarcinomas in relation to growth and prognosis: studies in xenografted tumours and clinico‐histopathological correlation in a series of 75 cases , 1985, Histopathology.
[22] H. Friess,et al. Enhanced expression of transforming growth factor β isoforms in pancreatic cancer correlates with decreased survival , 1993 .
[23] M. Nicholson,et al. Intragraft expression of transforming growth factor β1 gene in isolated glomeruli from human renal transplants , 1999, The British journal of surgery.
[24] H. Hameister,et al. Expression and differential regulation of connective tissue growth factor in pancreatic cancer cells , 1999, Oncogene.
[25] M. Sporn,et al. Macrophage production of transforming growth factor beta and fibroblast collagen synthesis in chronic pulmonary inflammation , 1989, The Journal of experimental medicine.
[26] Gary R. Grotendorst,et al. Production of transforming growth factor beta by human peripheral blood monocytes and neutrophils , 1989, Journal of cellular physiology.
[27] D. Rifkin,et al. TGF‐β Latency: Biological Significance and Mechanisms of Activation , 1997 .
[28] S. Wahl,et al. Transforming growth factor β: a matter of life and death , 1994 .
[29] D. Gospodarowicz. Growth factors and their action in vivo and in vitro , 1983, The Journal of pathology.
[30] H. Friess,et al. Overexpression of the epidermal growth factor receptor in human pancreatic cancer is associated with concomitant increases in the levels of epidermal growth factor and transforming growth factor alpha. , 1992, The Journal of clinical investigation.
[31] R. Takimoto,et al. Transforming growth factor beta 1 secreted from scirrhous gastric cancer cells is associated with excess collagen deposition in the tissue. , 1994, British Journal of Cancer.
[32] T. Stukel,et al. Immunohistochemical staining for transforming growth factor beta 1 associates with disease progression in human breast cancer. , 1992, Cancer research.
[33] J. Barrett,et al. Immunocytochemical study of transforming growth factor expression in benign and malignant gliomas. , 1989, The American journal of pathology.
[34] H. Yokozaki,et al. Expression of TGF‐β and procollagen type I and type III in human gastric carcinomas , 1989 .
[35] A. Abioye,et al. Pancreatic carcinoma. , 2020, Journal of the National Medical Association.
[36] L. Gold. The role for transforming growth factor-beta (TGF-beta) in human cancer. , 1999, Critical reviews in oncogenesis.
[37] M. Sporn,et al. Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[38] M. Ståhle-Bäckdahl. Increased Presence of Eosinophilic Granulocytes Expressing Transforming Growth Factor-ß1 in Collagenous Colitis , 2000, Scandinavian journal of gastroenterology.
[39] S. Wahl,et al. Transforming growth factor beta: a matter of life and death. , 1994, Journal of leukocyte biology.
[40] R. Hruban,et al. Exploring the host desmoplastic response to pancreatic carcinoma: gene expression of stromal and neoplastic cells at the site of primary invasion. , 2002, The American journal of pathology.
[41] Y. Luqmani,et al. Transcripts for transforming growth factors in human breast cancer: clinical correlates. , 1990, British Journal of Cancer.
[42] T. Yeatman,et al. Analysis of p53, p21WAF1, and TGF-beta1 in human ductal adenocarcinoma of the pancreas: TGF-beta1 protein expression predicts longer survival. , 1998, American journal of clinical pathology.
[43] H. Friess,et al. Expression and in‐situ localization of genes coding for extracellular matrix proteins and extracellular matrix degrading proteases in pancreatic cancer , 1995, International journal of cancer.
[44] K. Miyazono,et al. Transforming growth factor-beta: latent forms, binding proteins and receptors. , 1993, Growth factors.
[45] Y. Niitsu,et al. Immunohistochemical identification of type I procollagen in tumour cells of scirrhous adenocarcinoma of the stomach. , 1988, British Journal of Cancer.
[46] R. Walker,et al. Transforming growth factor beta 1 in ductal carcinoma in situ and invasive carcinomas of the breast. , 1992, European Journal of Cancer.
[47] N. Khalil. TGF-beta: from latent to active. , 1999, Microbes and infection.
[48] C. Powers,et al. Fibroblast growth factors, their receptors and signaling. , 2000, Endocrine-related cancer.
[49] D. Rifkin,et al. TGF-beta latency: biological significance and mechanisms of activation. , 1997, Stem cells.
[50] K. Takehara,et al. Induction of subcutaneous tissue fibrosis in newborn mice by transforming growth factor beta--simultaneous application with basic fibroblast growth factor causes persistent fibrosis. , 1997, Biochemical and biophysical research communications.
[51] Human ductal adenocarcinomas of the pancreas express extracellular matrix proteins. , 1994, British journal of cancer.
[52] H. Moses,et al. Transforming growth factor-beta increases steady state levels of type I procollagen and fibronectin messenger RNAs posttranscriptionally in cultured human dermal fibroblasts. , 1987, The Journal of clinical investigation.
[53] P. Brun,et al. Growth factors and collagen distribution in vernal keratoconjunctivitis. , 2000, Investigative ophthalmology & visual science.